Search results

Skip to results

Type

Status

Last updated

Showing 1 to 2 of 2 results for cipaglucosidase

  1. Cipaglucosidase alfa with miglustat for treating late-onset Pompe disease (TA912)

    Evidence-based recommendations on cipaglucosidase alfa (Pombiliti) with miglustat (Opfolda) for treating late-onset Pompe disease in adults.

    Technology appraisal guidance
    Published
    15 August 2023
    View recommendations

    Sections for TA912

  2. Cipaglucosidase alfa with miglustat for treating late-onset Pompe disease in people 12 to 17 years [TSID11887]

      Status ...

    Technology appraisal guidance
    Topic selection